FDA confirms type 2 diabetes drug link to bladder cancer
June 22, 2011 – As I told you earlier this week, France's drug authority recently told doctors to stop prescribing Actos based on a new study that links the type 2 diabetes drug to bladder cancer risk. Here in the U.S., FDA officials are not quite as cautious... Read More >


